Purpose: To determine the diagnostic accuracy of the sentinel lymph node pr
ocedure in patients with squamous cell carcinoma of the vulva and to invest
igate whether step sectioning and immunohistochemistry of sentinel lymph no
des increase the sensitivity for detection of metastases.
Patients and Methods: Between July 1996 and July 1999, 59 patients with pri
mary vulvar cancer were entered onto a two-center prospective study. All pa
tients underwent sentinel lymph node procedure with the combined technique
(preoperative lymphoscintigraphy with technetium-99m-labeled nanocolloid an
d intraoperative blue dye). Radical excision of the primary tumor with uni-
or bilateral inguinofemoral lymphadenectomy was performed subsequently. Se
ntinel lymph nodes and lymphadenectomy specimens were sent for histopatholo
gic examination separately, Sentinel lymph nodes, negative at the time of r
outine pathologic examination, were re-examined with step sectioning and im
munohistochemistry.
Results: In 59 patients, 107 inguinofemoral lymphadenectomies were performe
d (11 unilateral and 48 bilateral). All sentinel lymph nodes, as observed o
n preoperative lymphoscintigram, were identified successfully intraoperativ
ely. Routine histopathologic examination showed lymph node metastases in 27
groins, all of which were detected by the sentinel lymph node procedure, T
he negative predictive value for a negative sentinel lymph node was 100% (9
7.5% confidence interval [CI], 95% to 100%), Step sectioning and immunohist
ochemistry showed four additional metastases in 102 sentinel lymph nodes (4
%; 95% CI, 1% to 9%) that were negative at the time of routine histopatholo
gic examination,
Conclusion: Sentinel lymph node procedure with the combined technique is hi
ghly accurate in predicting the inguinofemoral lymph node status in patient
s with early-stage vulvar cancer. future trials should focus on the safe cl
inical implementation of the sentinel lymph node procedure in these patient
s, Step sectioning and immunohistochemistry slightly increase the sensitivi
ty of detecting metastases in sentinel lymph nodes and should be included i
n these trials. J Clin Oncol 18:2811-2816. (C) 2000 by American Society of
Clinical Oncology.